US stock index futures edged higher on Tuesday, staging a modest rebound after a broad selloff a day earlier as investors assessed the economic implications of President Donald Trump’s tariff policy and rising concerns about artificial intelligence disruption. Futures tied to the Dow Jones Industrial Average rose about 135 points, or 0.28%. S&P 500 futures
Alchemy Pay’s ACH token has been under heavy pressure in recent weeks. Since late January, the token has been locked in a relentless downtrend. ACH price chart | Source: Coingecko The upper resistance zone around $0.0120–$0.0125 marked the start of the selling pressure. From that point, ACH has steadily moved lower without any meaningful recovery.
As interest in tokenised real-world assets and on-chain derivatives has grown, Ostium has emerged as a significant participant in the segment. The platform is built around the idea that trading is becoming more cross-asset and increasingly influenced by macroeconomic developments. In 2025, the company reported strong growth in volumes, user numbers, and open interest, alongside
JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon said growing competitive pressures across finance are beginning to resemble conditions that preceded the 2008 financial crisis, raising concerns about risk-taking in lending markets. Speaking to investors during a company update, Dimon said some lenders appear to be loosening standards in pursuit of profit growth, particularly
Salesforce’s stock price continued its strong downward trend this week, reaching its lowest level since March 2023. CRM dropped to $178, down by over 50% from its highest level in 2025, with its market capitalisation falling from $378 billion to the current $166 billion, as focus shifts to the upcoming financial results. Salesforce stock tumbles
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel. It dropped to a low of $10.50 on Friday, down sharply from the all-time high of $25.20. This retreat has brought its market capitalization to $15.4 billion from a record high of
Fridays used to be reserved for routine headlines. But since Donald Trump’s reelection, every Friday seems like a bombshell day. And last Friday delivered a constitutional jolt to global trade. In a 6–3 ruling, the US Supreme Court struck down President Donald Trump’s use of emergency powers to impose sweeping tariffs, removing the executive “on-off
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its portfolio and ensure smoother launches of new medicines. The move comes as the drugmaker seeks to prepare for mounting sales pressure later this decade, driven by the looming loss of exclusivity for
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its all-time high. It has soared by 160% in the last five years, beating JPMorgan, which has jumped by over 133% in the same period. So, will the rally accelerate as the company
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to refill, and one more item for the sharps bin. Eli Lilly is trying to make that routine feel less like a chore. The company says it has launched a new Zepbound KwikPen